Prolactin level during 5 years of risperidone treatment in patients with psychotic disorders
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Objective: To investigate prolactin levels and related side effects in 128 men and 90 women initially treated with risperidone. Method: Patients initially treated with risperidone were followed over 5 years, during which 45% were switched to other antipsychotic drugs. Results: Initially, prolactin levels were fivefold the norm in women, and threefold in men. Diagnosis did not affect the prolactin level if adjustment for sex, current age, and age at onset of psychosis was applied. Prolactin levels did not correlate significantly neither with any Positive and Negative Symptom Scale item or subscale, nor with side effects. Drugs other than risperidone were not associated with high prolactin levels. For patients on continuous monotherapy risperidone treatment, there was a marked linear reduction of prolactin level over all 5 years. Conclusion: Risperidone induces a higher prolactin elevation than other atypical antipsychotics, but the effect adapts over time. Prolactin was not associated with expected side effects (e.g. sexual, mental, or weight gain).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lingjærde, O., Ahlfors, U. G., Bech, P., Dencker, S. J., & Elgen, K. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb10566.x · Cited by 1,705
Prolactin and Growth Hormone in the Regulation of the Immune System
Gala, R. R. (1991) · Experimental Biology and Medicine · doi:10.3181/00379727-198-43286b · Cited by 318 · cited 1×
“However, it has also been suggested to play a role in many other biological functions such as reproduction, glucose metabolism and in regulation of the immune system (10).”
Sexual dysfunction and antipsychotic treatment
Cutler, A. J. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00113-0 · Cited by 176 · cited 1×
“Our data do not support the assumption that sexual dysfunction among psychotic patients treated by antipsychotic drugs is caused to a substantial degree by prolactin increase, as suggested by Cutler (42).”
Osteoporosis in Patients With Schizophrenia
Hummer, M., Malik, P., Gasser, R. W., Hofer, A., Kemmler, G., Moncayo Naveda, R. C., Rettenbacher, M. A., & Fleischhacker, W. W. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.162 · Cited by 125 · cited 1×
“(18) an assumed relationship between osteoporosis and prolactin-increasing antipsychotics could not be corroborated, except and maybe for men and one anatomical structure (mineral loss in the lumbar region).”
Cited by
Peuskens, J., Pani, L., Detraux, J., & De Hert, M. (2014) · CNS Drugs · doi:10.1007/s40263-014-0157-3 · Cited by 350
Women’s sexual dysfunction associated with psychiatric disorders and their treatment
Basson, R., & Gilks, T. (2018) · Women's Health · doi:10.1177/1745506518762664 · Cited by 225
Are sexual side effects of prolactin-raising antipsychotics reducible to serum prolactin?
Knegtering, H., van den Bosch, R., Castelein, S., Bruggeman, R., Sytema, S., & van Os, J. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.02.008 · Cited by 91
“Although it has been suggested that prolactin elevation plays an important role in the occurrence of antipsychoticinduced sexual side effects (SSE) such as diminished libido, diminished arousal (lubrication or erection) and disturbance of orgasm, the evidence is not conclusive (Wieck and Haddad, 2002; Eberhard et al.,…”
BackgroundBerwaerts, J., Cleton, A., Rossenu, S., Talluri, K., Remmerie, B., Janssens, L., Boom, S., Kramer, M., & Eerdekens, M. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109106914 · Cited by 49
“…suggested a relatively stronger correlation of serum prolactin concentrations with the plasma concentrations of paliperidone than with risperidone plasma concentrations after administration of risperidone IR (Knegtering et al., 2005; Melkersson, 2006; Eberhard et al., 2007; Troost et al., 2007).”
BackgroundResultInfluential
Metadata
- Authors
- Eberhard, J., Lindström, E., Holstad, M., & Levander, S.
- Venue
- Acta Psychiatrica Scandinavica
- Publisher
- Wiley
- Published
- 2007-03-13
- Volume
- 115
- Issue
- 4
- Pages
- 268-276
- ISSN
- 0001-690X (ISSN-L)
- 1600-0447
- OpenAlex
- W2160220376
- Cited by
- 57
- References
- 4
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.